• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类神经母细胞瘤中17号染色体长臂的杂乱易位。

Promiscuous translocations of chromosome arm 17q in human neuroblastomas.

作者信息

Lastowska M, Roberts P, Pearson A D, Lewis I, Wolstenholme J, Bown N

机构信息

Department of Human Genetics, University of Newcastle upon Tyne, U.K.

出版信息

Genes Chromosomes Cancer. 1997 Jul;19(3):143-9.

PMID:9218994
Abstract

Deletions of chromosome arm 1p and amplification of the MYCN oncogene are well-recognized genetic changes in neuroblastoma cells. Technical difficulties in cytogenetic analysis of this tumour have hampered the recognition of other recurring abnormalities, but recent use of molecular cytogenetic techniques has indicated significant involvement of chromosome arm 17q. In primary tumours and in cell lines, a recurrent unbalanced translocation t(1p;17q) has been identified by fluorescence in situ hybridization. We confirm the occurrence of this translocation in primary tumours and, in addition, we describe seven new structural rearrangements all of which result in gain of 17q in tumour cells. These rearrangements involved chromosome arms 9p, 10q, 11p, 14q, and 16q. Triplication of the 17q arm was seen in one case. The 17q breakpoint was most commonly q21. All these 17q changes were found in near-diploid tumours. We have also reviewed the literature for neuroblastoma karyotypes involving 17q abnormalities; taken in conjunction with our findings this indicates a remarkable promiscuity of translocation partners, with more than 20 different chromosome regions involved in 17q translocations.

摘要

染色体1p臂缺失和MYCN癌基因扩增是神经母细胞瘤细胞中公认的基因变化。该肿瘤细胞遗传学分析中的技术难题阻碍了对其他复发性异常的识别,但最近分子细胞遗传学技术的应用表明染色体17q臂有显著受累。在原发性肿瘤和细胞系中,通过荧光原位杂交已鉴定出一种复发性不平衡易位t(1p;17q)。我们证实了这种易位在原发性肿瘤中的发生,此外,我们还描述了7种新的结构重排,所有这些重排均导致肿瘤细胞中17q增加。这些重排涉及染色体臂9p、10q、11p、14q和16q。1例中可见17q臂三倍体。17q断点最常见于q21。所有这些17q变化均在近二倍体肿瘤中发现。我们还查阅了涉及17q异常的神经母细胞瘤核型的文献;结合我们的研究结果,这表明易位伙伴存在显著的混杂性,超过20个不同的染色体区域参与了17q易位。

相似文献

1
Promiscuous translocations of chromosome arm 17q in human neuroblastomas.人类神经母细胞瘤中17号染色体长臂的杂乱易位。
Genes Chromosomes Cancer. 1997 Jul;19(3):143-9.
2
Distinct cytogenetic pathways of advanced-stage neuroblastoma tumors, detected by spectral karyotyping.通过光谱核型分析检测到的晚期神经母细胞瘤肿瘤的不同细胞遗传学途径。
Genes Chromosomes Cancer. 2002 Jul;34(3):313-24. doi: 10.1002/gcc.10082.
3
Stepwise occurrence of a complex unbalanced translocation in neuroblastoma leading to insertion of a telomere sequence and late chromosome 17q gain.神经母细胞瘤中复杂不平衡易位的逐步发生,导致端粒序列插入和晚期17号染色体长臂获得。
Oncogene. 2005 May 5;24(20):3377-84. doi: 10.1038/sj.onc.1208486.
4
MYCN amplification and 17q in neuroblastoma: evidence for structural association.神经母细胞瘤中的MYCN扩增与17号染色体长臂:结构关联的证据
Genes Chromosomes Cancer. 2001 Jan;30(1):87-90.
5
Molecular cytogenetic analysis of recurrent unbalanced t(11;17) in neuroblastoma.神经母细胞瘤中复发性不平衡易位t(11;17)的分子细胞遗传学分析
Cancer Genet Cytogenet. 2004 Oct 1;154(1):44-51. doi: 10.1016/j.cancergencyto.2004.04.003.
6
Molecular cytogenetic definition of 17q translocation breakpoints in neuroblastoma.神经母细胞瘤中17q易位断点的分子细胞遗传学定义
Med Pediatr Oncol. 2001 Jan;36(1):20-3. doi: 10.1002/1096-911X(20010101)36:1<20::AID-MPO1006>3.0.CO;2-E.
7
Comparing histopathological classification with MYCN, 1p36 and 17q status detected by fluorescence in situ hybridisation from 14 untreated primary neuroblastomas in Singapore.比较未经治疗的新加坡 14 例原发性神经母细胞瘤的组织病理学分类与荧光原位杂交检测的 MYCN、1p36 和 17q 状态。
Singapore Med J. 2009 Nov;50(11):1090-4.
8
Gain of distal chromosome arm 17q is not associated with poor prognosis in neuroblastoma.17号染色体长臂远端的扩增与神经母细胞瘤的不良预后无关。
Clin Cancer Res. 2003 Oct 15;9(13):4835-40.
9
Variety and complexity of chromosome 17 translocations in neuroblastoma.神经母细胞瘤中17号染色体易位的多样性和复杂性。
Genes Chromosomes Cancer. 2004 Feb;39(2):143-50. doi: 10.1002/gcc.10313.
10
der(11)t(11;17): a distinct cytogenetic pathway of advanced stage neuroblastoma (NBL) - detected by spectral karyotyping (SKY).der(11)t(11;17):晚期神经母细胞瘤(NBL)的一种独特细胞遗传学途径——通过光谱核型分析(SKY)检测到。
Cancer Lett. 2003 Jul 18;197(1-2):75-9. doi: 10.1016/s0304-3835(03)00083-1.

引用本文的文献

1
17q Gain in Neuroblastoma: A Review of Clinical and Biological Implications.神经母细胞瘤中17号染色体长臂增益:临床和生物学意义综述
Cancers (Basel). 2024 Jan 12;16(2):338. doi: 10.3390/cancers16020338.
2
The role of genetic and epigenetic alterations in neuroblastoma disease pathogenesis.遗传和表观遗传改变在神经母细胞瘤发病机制中的作用。
Pediatr Surg Int. 2013 Feb;29(2):101-19. doi: 10.1007/s00383-012-3239-7. Epub 2012 Dec 29.
3
The effect of miR-338-3p on HBx deletion-mutant (HBx-d382) mediated liver-cell proliferation through CyclinD1 regulation.
miR-338-3p 通过调节 CyclinD1 对 HBx 缺失突变体(HBx-d382)介导的肝细胞增殖的影响。
PLoS One. 2012;7(8):e43204. doi: 10.1371/journal.pone.0043204. Epub 2012 Aug 17.
4
Novel chromosomal rearrangements and break points at the t(6;9) in salivary adenoid cystic carcinoma: association with MYB-NFIB chimeric fusion, MYB expression, and clinical outcome.涎腺腺样囊性癌中 t(6;9)的新型染色体重排和断裂点:与 MYB-NFIB 嵌合融合、MYB 表达和临床结果的关联。
Clin Cancer Res. 2011 Nov 15;17(22):7003-14. doi: 10.1158/1078-0432.CCR-11-1870. Epub 2011 Oct 5.
5
Comprehensive analysis of the MYB-NFIB gene fusion in salivary adenoid cystic carcinoma: Incidence, variability, and clinicopathologic significance.全面分析唾液腺腺样囊性癌中的 MYB-NFIB 基因融合:发生率、变异性及临床病理意义。
Clin Cancer Res. 2010 Oct 1;16(19):4722-31. doi: 10.1158/1078-0432.CCR-10-0463. Epub 2010 Aug 11.
6
Translocation t(6;14) as the sole chromosomal abnormality in adenoid cystic carcinoma of the base of tongue.6号和14号染色体易位作为舌根部腺样囊性癌唯一的染色体异常情况。
Head Neck Pathol. 2007 Dec;1(2):165-8. doi: 10.1007/s12105-007-0030-5. Epub 2007 Oct 26.
7
Cytogenetic evaluation of neuroblastoma using fine needle aspiration cultures.
Pediatr Surg Int. 2009 Nov;25(11):939-43. doi: 10.1007/s00383-009-2446-3.
8
Neuroblastoma tumour genetics: clinical and biological aspects.神经母细胞瘤肿瘤遗传学:临床与生物学方面
J Clin Pathol. 2001 Dec;54(12):897-910. doi: 10.1136/jcp.54.12.897.
9
Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2(SSTR2) gene at 17q24.17号染色体长臂的获得与神经母细胞瘤的不良预后相关,但不涉及17q24处生长抑素受体2(SSTR2)基因的突变。
Br J Cancer. 1999 Dec;81(8):1402-9. doi: 10.1038/sj.bjc.6692231.